Hajimu Kurumatani

This inventor holds 16 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Toray Industries, Inc., Nanotheta Co., Ltd.. Active years: 1991-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hajimu Kurumatani. Retrieved from https://idiyas.com/inventor/hajimu-kurumatani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 3)

% Patents Active = 93.8

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 3.2

ph-index = 5

Forward Citations = 99(Granted Patents)

Location History:

Kamakura, JP (1991 - 2016)
Fujisawa, JP (2017)
Kanagawa, JP (1997 - 2018)
Tokyo, JP (2018)

Company Filing History:

16 out of 3,581

Toray Industries, Inc.

where one patent can have more than one assignee

Years Active: 1991-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12325677 - Carboxylic acid-type lipid, and lipid particle and lipid membrane each comprising carboxylic acid-type lipid (2025-06-10),

2. 12097177 - Therapeutic method for cat with chronic kidney disease (2024-09-24),

3. 10149909 - Fortifier (2018-12-11),

4. 9913825 - Method of ameliorating uremia (2018-03-13),

5. 9783518 - Therapeutic agent and treatment method for ameliorating uremia (2017-10-10),

6. 9546145 - Combination therapy for the treatment of chronic renal failure with an angiotensin II receptor antagonist and beraprost (2017-01-17),

7. 9457032 - Therapeutic agent for renal failure (2016-10-04),

8. 8575175 - Therapeutic agent for chronic renal failure (2013-11-05),

9. 6653345 - C-C chemokine synthesis inhibitor (2003-11-25),

10. 6340693 - Protective agent for nervous system structural cells (2002-01-22),

11. 6232343 - Ophthalmic preparations (2001-05-15),

12. 6127413 - Ocular depressor (2000-10-03),

13. 6046233 - Agent for treating cor pulmonale (2000-04-04),

14. 5981594 - Method of treatment for diabetic neuropathy (1999-11-09),

15. 5632776 - Implantation materials (1997-05-27),

Title: Hajimu Kurumatani: Innovator in Lipid Technology and Veterinary Medicine

Introduction

Hajimu Kurumatani is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the fields of lipid technology and veterinary medicine. With a total of 16 patents to his name, Kurumatani's work has the potential to impact both human health and animal care.

Latest Patents

Among his latest patents, Kurumatani has developed a carboxylic acid-type lipid that can enhance the adhesion and aggregation of platelets. This innovation is noteworthy because it functions effectively even without the presence of proteins or peptides typically involved in these processes. Additionally, he has created a therapeutic method for cats suffering from chronic kidney disease. This method aims to inhibit the progression of the disease and improve the overall survival rate of affected cats.

Career Highlights

Throughout his career, Hajimu Kurumatani has worked with notable companies such as Toray Industries, Inc. and Nanotheta Co., Ltd. His experience in these organizations has allowed him to refine his expertise in lipid technology and therapeutic applications.

Collaborations

Kurumatani has collaborated with esteemed colleagues, including Ayako Kawashima and Masafumi Isogaya. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Hajimu Kurumatani's contributions to lipid technology and veterinary medicine exemplify the impact of innovative thinking in addressing health challenges. His patents and collaborative efforts continue to pave the way for advancements in these critical fields.

Profile summary based on public USPTO records.